According to Fortune Business Insights, the global AI in clinical trials market size was valued at USD 3.8 billion in 2025 and is projected to grow from USD 5.5 billion in 2026 to USD 77.30 billion by 2034, exhibiting a CAGR of 39.14% during the forecast period. North America dominated the AI in clinical trials market with a market share of 52.26% in 2025.
The AI in clinical trials market is transforming the clinical research landscape by supporting pharmaceutical companies, biotechnology organizations, contract research organizations, and healthcare institutions in improving trial planning, patient identification, data management, and operational decision-making. Artificial intelligence technologies can analyze complex datasets, identify patterns, automate repetitive activities, and support researchers throughout different stages of clinical research. Growing investment in digital healthcare, increasing clinical trial complexity, and the need to improve research efficiency are encouraging the adoption of AI-enabled solutions.
Continue reading for more details:
https://www.fortunebusinessinsights.com/ai-in-clinical-trials-market-114081
The AI in clinical trials market can be segmented based on offering, technology, application, end user, and other relevant categories. Based on offering, the market includes software and services. AI-enabled software solutions can assist researchers with data analysis, patient recruitment, trial design, monitoring, and other research activities. Services provide organizations with implementation, integration, consulting, and specialized support to help incorporate artificial intelligence into clinical research workflows.
Based on technology, the AI in clinical trials market includes machine learning, natural language processing, deep learning, and other artificial intelligence technologies. Machine learning can help identify patterns within clinical datasets and support predictive analysis. Natural language processing can assist organizations in processing large volumes of unstructured medical and clinical information. Deep learning can support advanced analytical applications where large and complex datasets need to be interpreted.
Based on application, AI in clinical trials is used for patient recruitment, clinical trial design, patient monitoring, data management, safety and pharmacovigilance, outcome prediction, and other research activities. Patient recruitment is an important application because identifying suitable participants can be challenging and time-consuming. AI can support researchers in matching patient information with study requirements and improving the efficiency of recruitment processes.
By end user, the AI in clinical trials market serves pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions, and other healthcare organizations. Pharmaceutical and biotechnology companies are increasingly adopting AI solutions to improve research productivity and support drug development activities. Contract research organizations can use AI technologies to enhance clinical trial management and provide advanced services to sponsors.
The AI in clinical trials market is experiencing rapid development as clinical research organizations increasingly seek technologies that can improve efficiency, accelerate data analysis, and support evidence-based decision-making. Clinical trials generate extensive amounts of structured and unstructured information, creating opportunities for artificial intelligence to automate data-intensive activities and identify relevant insights.